omation mbers - Society for Laboratory Automation and Screening
omation mbers - Society for Laboratory Automation and Screening omation mbers - Society for Laboratory Automation and Screening
12:00 pm Wednesday, February 4 High Throughput Screening – Analytical Room A2 Rebecca Zangmeister National Institute of Standards and Technology 100 Bureau Drive, MS 8362 Gaithersburg, Maryland 20899 razang@nist.gov Integration of Hydrogel Based Bioassays Into Microfluidic Channels 64 Co-Author(s) Michael J. Tarlov We previously reported a method for immobilizing single-stranded DNA (ss-DNA) probe molecules in polyacrylamide hydrogels within plastic microfluidic channels. Low concentrations of fluorescent-tagged ss-DNA targets hybridize with immobilized probes and are detected in the hydrogels. We aim to couple two novel bioassays with this basic technology. The first is a diagnostic DNA assay that does not require pre-labeling of the target strand prior to analysis. The assay is based on the displacement of a short sacrificial fluorescent-tagged indicator oligomer by a longer untagged target sequence as it is electrophoresed through a DNA-containing hydrogel plug immobilized in a microfluidic channel. The distinct advantage of this assay is the ability to detect non-labeled target DNA. The second is a lead sensitive assay, based on the response of catalytic DNA to Pb(II) ions. Our goal is to immobilize the enzyme strand sequence of the catalytic DNA duplex in a hydrogel plug immobilized in a microfluidic channel. Fluorescently tagged substrate strands are electrophoresed into the hydrogel plug where they hybridize with the immobilized enzyme strands, forming the catalytic DNA system. Electrophoretic migration of Pb(II) ions through the hydrogel plug results in catalytic cleavage of the substrate strand and release of the fluorescent-tagged sequence fragment that is detected in a second capture plug. Both assays feature enhanced sensitivity due to high loading of DNA probes in the hydrogel plugs, the spatially confined, directed mass transfer characteristics of the microfluidic channels, and the inherently low fluorescent background of the hydrogels. 3:30 pm Wednesday, February 4 High Throughput Screening – Data Analysis and QC Room A2 Anthony Carlo Pfizer Eastern Point Road Groton, Connecticut 06340 Anthony_A_Carlo@groton.pfizer.com Evotec µHTS Data Analysis – Making the Most of the Multiparametric Readout This presentation will discuss our efforts towards improving hit detection in lead discovery by increasing the confidence of identifying true positives verses false positives/negatives in primary HTS data. Towards this goal, the talk will focus on the use of single molecule fluorescence detection provided by the Evotec OAI µHTS platform, which provides multi-parametric data readout from miniaturized assay formats and how this information is processed. These techniques will be applied across multiple HTS assays.
4:00 pm Wednesday, February 4 High Throughput Screening – Data Analysis and QC Room A2 Hanspeter Gubler Novartis Institutes for BioMedical Research WSJ-350.E15 Basel, CH-4002 Switzerland hanspeter.gubler@pharma.novartis.com 65 Co-Author(s) Michel Girod, Sigmar Dressler, Rochdi Bouhelal, Daniela Gabriel, Johannes Ottl, Kamal Azzaoui HTS Data Analysis in the Real World: Practical Experience With HTS Data Quality Assurance Systems and Recent Integration of the GeneData Screener Software The application of comprehensive quality control and sophisticated data correction algorithms to High Throughput Screening (HTS) data has a long standing history in the NIBR Lead Discovery Center (LDC). Fully automated inhouse systems are sifting through HTS raw data to check quality and to detect and correct many systematic errors. Some lacking aspects – most importantly interactive data visualization, comprehensive statistical analyses and possibilities for easy cross-assay investigations – have led NIBR to enter into a system development collaboration with GeneData in 2002. The GeneData “Screener” software is tightly integrated to the LDC HTS data processing systems. Standardized instrument raw data with necessary experimental context information are automatically entering the “Screener” system in a near “real time” fashion. Data are thus readily available to the scientists for analysis and – if necessary – correction of systematic patterns. Additional software modules are used for hit selection, including results from other assays, either historical or direct counter screens. The combination of advanced assay technology with the application of sophisticated quality control, error detection and data correction algorithms (quality assurance) lead to improvements in HTS efficiency. We demonstrate this with a few case studies from our HTS labs. In addition, we provide some further insight into the performance of the pattern correction algorithms by applying them to simulated data of known intrinsic activity – and error structure. 4:30 pm Wednesday, February 4 High Throughput Screening – Data Analysis and QC Room A2 Maneessha Altekar GlaxoSmithKline 709 Swedeland Road, Mail Stop UW2110 King of Prussia, Pennsylvania 19406-0939 maneesha.2.altekar@gsk.com On-Line QC for High Throughput Screening Co-Author(s) Glenn Hofmann, Isabel Coma, Jesus Herranz, Liz Clark, Gavin Harper, Mark Lennon, Frances Stewart GlaxoSmithKline’s migration from the HTS laboratory to the HTS automation factory is expected to result in greater throughput for screening. Thus there is a need to put data analysis systems in place to monitor the quality of the screens in real time to ensure that any wastage of compounds, reagents and other materials is held to a minimum if things go wrong during a run. The on-line QC process has been developed to perform plate level calculations and determine the health of a plate or the screening run at any given time according to specified business rules. Initially, plate failures or run stoppages due to business rules will be rare as screeners gain experience with using the system and evaluate the sensitivity of the business rules being applied. The initial purpose of the system is diagnosis rather than remedy, with the screeners being informed of problems as they occur. The ultimate goal is to automate the system to provide feedback in to the screening process that will result in the robotic platform pausing or stopping the run as appropriate. PODIUM ABSTRACTS
- Page 16 and 17: CONFERENCE AT A GLANCE 8:30 am - 4:
- Page 18 and 19: PROGRAM Sunday, February 1, 2004 8:
- Page 20 and 21: 5:00 - 6:30 pm Reception in the San
- Page 22 and 23: Wednesday, February 4, 2004 (contin
- Page 24 and 25: Thursday, February 5, 2004 (continu
- Page 26 and 27: Thursday, February 5, 2004 (continu
- Page 28 and 29: NOTES 26
- Page 30 and 31: TP014 A Novel System for Automated
- Page 32 and 33: TP040 Mass Production of Plastic Ch
- Page 34 and 35: TP067 Neurons as Sensors: Mixed Che
- Page 36 and 37: These posters should be put up on W
- Page 38 and 39: WP026 Fully-Automated, High Through
- Page 40 and 41: WP054 Innovations in Photonics for
- Page 42 and 43: WP083 Development of an Automated H
- Page 44 and 45: NOTES 42
- Page 46 and 47: 10:30 am Tuesday, February 3 Plenar
- Page 48 and 49: 4:00 pm Tuesday, February 3 HT Chem
- Page 50 and 51: 9:00 am Wednesday, February 4 HT Ch
- Page 52 and 53: 11:30 am Wednesday, February 4 HT C
- Page 54 and 55: 4:30 pm Wednesday, February 4 HT Ch
- Page 56 and 57: 9:00 am Thursday, February 5 HT Che
- Page 58 and 59: 11:30 am Thursday, February 5 High
- Page 60 and 61: 3:00 pm Thursday, February 5 Discov
- Page 62 and 63: 4:30 pm Tuesday, February 3 High Th
- Page 64 and 65: 9:30 am Wednesday, February 4 High
- Page 68 and 69: 5:00 pm Wednesday, February 4 High
- Page 70 and 71: 9:30 am Thursday, February 5 High T
- Page 72 and 73: 4:30 pm Tuesday, February 3 Microfl
- Page 74 and 75: 9:30 am Wednesday, February 4 Micro
- Page 76 and 77: 12:00 pm Wednesday, February 4 Micr
- Page 78 and 79: 5:00 pm Wednesday, February 4 Micro
- Page 80 and 81: 9:30 am Thursday, February 5 Microc
- Page 82 and 83: 1:30 pm Thursday, February 5 Microf
- Page 84 and 85: 3:00 pm Tuesday, February 3 Proteom
- Page 86 and 87: 8:00 am Wednesday, February 4 Prote
- Page 88 and 89: 10:30 am Wednesday, February 4 Prot
- Page 90 and 91: 3:30 pm Wednesday, February 4 Prote
- Page 92 and 93: 8:00 am Thursday, February 5 Proteo
- Page 94 and 95: 10:30 am Thursday, February 5 Prote
- Page 96 and 97: 2:00 pm Thursday, February 5 Automa
- Page 98 and 99: 3:30 pm Tuesday, February 3 Genomic
- Page 100 and 101: 8:30 am Wednesday, February 4 Genom
- Page 102 and 103: 11:00 am Wednesday, February 4 Geno
- Page 104 and 105: 4:00 pm Wednesday, February 4 Genom
- Page 106 and 107: 8:30 am Thursday, February 5 Genomi
- Page 108 and 109: 11:00 am Thursday, February 5 Genom
- Page 110 and 111: 3:00 pm Tuesday, February 3 Clinica
- Page 112 and 113: 8:00 am Wednesday, February 4 Clini
- Page 114 and 115: 10:30 am Wednesday, February 4 Clin
12:00 pm Wednesday, February 4 High Throughput <strong>Screening</strong> – Analytical Room A2<br />
Rebecca Zangmeister<br />
National Institute of St<strong>and</strong>ards <strong>and</strong> Technology<br />
100 Bureau Drive, MS 8362<br />
Gaithersburg, Maryl<strong>and</strong> 20899<br />
razang@nist.gov<br />
Integration of Hydrogel Based Bioassays Into Microfluidic Channels<br />
64<br />
Co-Author(s)<br />
Michael J. Tarlov<br />
We previously reported a method <strong>for</strong> immobilizing single-str<strong>and</strong>ed DNA (ss-DNA) probe molecules in<br />
polyacrylamide hydrogels within plastic microfluidic channels. Low concentrations of fluorescent-tagged ss-DNA<br />
targets hybridize with immobilized probes <strong>and</strong> are detected in the hydrogels. We aim to couple two novel bioassays<br />
with this basic technology. The first is a diagnostic DNA assay that does not require pre-labeling of the target str<strong>and</strong><br />
prior to analysis. The assay is based on the displacement of a short sacrificial fluorescent-tagged indicator oligomer<br />
by a longer untagged target sequence as it is electrophoresed through a DNA-containing hydrogel plug immobilized<br />
in a microfluidic channel. The distinct advantage of this assay is the ability to detect non-labeled target DNA. The<br />
second is a lead sensitive assay, based on the response of catalytic DNA to Pb(II) ions. Our goal is to immobilize<br />
the enzyme str<strong>and</strong> sequence of the catalytic DNA duplex in a hydrogel plug immobilized in a microfluidic channel.<br />
Fluorescently tagged substrate str<strong>and</strong>s are electrophoresed into the hydrogel plug where they hybridize with the<br />
immobilized enzyme str<strong>and</strong>s, <strong>for</strong>ming the catalytic DNA system. Electrophoretic migration of Pb(II) ions through the<br />
hydrogel plug results in catalytic cleavage of the substrate str<strong>and</strong> <strong>and</strong> release of the fluorescent-tagged sequence<br />
fragment that is detected in a second capture plug. Both assays feature enhanced sensitivity due to high loading of<br />
DNA probes in the hydrogel plugs, the spatially confined, directed mass transfer characteristics of the microfluidic<br />
channels, <strong>and</strong> the inherently low fluorescent background of the hydrogels.<br />
3:30 pm Wednesday, February 4 High Throughput <strong>Screening</strong> – Data Analysis <strong>and</strong> QC Room A2<br />
Anthony Carlo<br />
Pfizer<br />
Eastern Point Road<br />
Groton, Connecticut 06340<br />
Anthony_A_Carlo@groton.pfizer.com<br />
Evotec µHTS Data Analysis – Making the Most of the Multiparametric Readout<br />
This presentation will discuss our ef<strong>for</strong>ts towards improving hit detection in lead discovery by increasing the<br />
confidence of identifying true positives verses false positives/negatives in primary HTS data. Towards this goal, the<br />
talk will focus on the use of single molecule fluorescence detection provided by the Evotec OAI µHTS plat<strong>for</strong>m,<br />
which provides multi-parametric data readout from miniaturized assay <strong>for</strong>mats <strong>and</strong> how this in<strong>for</strong>mation is<br />
processed. These techniques will be applied across multiple HTS assays.